Unibio CIS ApS: Financial statements 2019
CVR: 37456136
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Unibio CIS ApS (CVR 37456136) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -21,000 and a net result of DKK -13,000 compared with DKK -263,000 the year before. Equity in the 2019 report amounted to DKK 29,000. The solvency ratio was 1.3%.
- Gross Profit
- DKK -21,000
- Profit/Loss
- DKK -13,000
- Equity
- DKK 29,000
- Total Assets
- DKK 2,285,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -21 t. | -13 t. | 29 t. | 0 |
| 2018 | - | -341 t. | -263 t. | 42 t. | 0 |
| 2017 | - | 94 t. | 18 t. | 305 t. | - |
| 2016 | - | 279 t. | 237 t. | 287 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Unibio CIS ApS has published its annual report for 2018. Gross profit came to DKK -341,000, and the net result was DKK -263,000.
About Unibio CIS ApS
Unibio CIS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named UniBio Russia ApS. The management consists of Søren Olrik Eklund and Jess Dragheim. The company is owned by UNIBIO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 2,100,000 and a net result of DKK 2,068,000 compared with DKK -2,197,000 the year before. Equity in the 2025 report amounted to DKK 2,417,000.